Fatal acute tumor lysis syndrome, hepatic encephalopathy and flare phenomenon following combined androgen blockade

Journal of Urology

Volumn 171, Issue 4, 2004, Pages 1627-

  Tanvetyanon, Tawee ^a,c   Choudhury, Abdul M ^b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b Psychology Service   (United States)

^c LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

Author keywords

Androgen antagonists; Hepatic encephalopathy; Prostatic neoplasms; Tumor lysis syndrome

Indexed keywords

ANTIANDROGEN; FLUTAMIDE; GOSERELIN;

AGED; ARTICLE; CANCER HORMONE THERAPY; CASE REPORT; DISEASE EXACERBATION; FATALITY; HEPATIC ENCEPHALOPATHY; HUMAN; LETHARGY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; TREMOR; TUMOR CELL DESTRUCTION;

EID: 1642320262     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000115884.21275.f4     Document Type: Article

References (3)

1. Baeksgaard, L. and Sorensen, J. B.: Acute tumor lysis syndrome in solid tumors-a case report and review of the literature. Cancer Chemother Pharmacol, 51: 187, 2003
2. Cech, P., Block, J. B., Cone, L. A. and Stone, R.: Tumor lysis syndrome after tamoxifen flare. N Engl J Med, 315: 263, 1986
3. Plotkin, D., Lechner, J. J., Jung, W. E. and Rosen, P. J.: Tamoxifen flare in advanced breast cancer. JAMA, 240: 2644, 1978